Literature DB >> 28552113

Preliminary study on investigation of zoonotic visceral leishmaniasis in endemic foci of Ethiopia by detecting Leishmania infections in rodents.

Wossenseged Lemma1, Asrat Bizuneh2, Habte Tekie3, Habtamu Belay2, Hirut Wondimu2, Aysheshm Kassahun4, Welelta Shiferaw2, Meshesha Balkew5, Ibrahim Abassi6, Gad Baneth7, Asrat Hailu2.   

Abstract

OBJECTIVE: To investigate the zoonotic visceral leishmaniasis (ZVL) by identification of the most probable reservoir hosts using parasite isolation and analysis of a possible transmission dynamics of the disease in extra-domestic agricultural fields and rural villages.
METHODS: Rodents were collected from selected study sites in kala-azar endemic areas based on information for localities of kala-azar cases for screening of Leishmania infections using parasitological, serological and polymerase chain reaction (PCR) from March, 2013 to January, 2014. Ketamine (Clorketam Veterinary) was used to anaesthesize the rodents according the prescribed dosage (average 2 mg/kg for intra-venous route). The blood obtained using sterile needle was dropped into sterile filter paper and allowed to air dry before sealing in plastic bags. The tissues from liver, spleen and skin were macerated in Locke's solution before transferring them into NNN medium. Blood and touch smears of liver, spleen, skin and bone marrow were prepared for fixing using methanol and staining by Giemsa stain for microscopy. These tissues were also used for DNA extractions and PCR amplification of Leishmania infection.
RESULTS: A total of 335 rodents (13 species) were analyzed by sampling internal organs. The infection rate by PCR was 11.1% (6/54) for Arvicanthis nilothicus compared to 17.6% (3/17) and 12.5% (2/16) for Acomys cahirinus and Tarera (G) robustus respectively. Almost all the infections were found from bone marrow samples (8/48 or 16.7%) compared with 1/91 (1.1%) liver, 2/87 (2.2%) spleen and 0/87 (0%) skin. In all study sites with past human VL cases, rodents and proved vectors shared similar habitats.
CONCLUSIONS: Leishmania donovani might circulate among different species of rodents in kala-azar endemic lowlands and valleys of Ethiopia by Phlebotomus orientalis and Phlebotomus martini. Detailed studies to substantiate the preliminary data on the possible role of these rodents are urgently needed.
Copyright © 2017 Hainan Medical University. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ethiopia; Leishmania donovani; Phlebotomus martini; Phlebotomus orientalis; Reservoir hosts; Zoonotic visceral leishmaniasis

Year:  2017        PMID: 28552113     DOI: 10.1016/j.apjtm.2017.03.018

Source DB:  PubMed          Journal:  Asian Pac J Trop Med        ISSN: 1995-7645            Impact factor:   1.226


  4 in total

1.  Description of malaria epidemics and normal transmissions using rainfall variability in Gondar Zuria highland District, Ethiopia.

Authors:  Wossenseged Lemma
Journal:  Heliyon       Date:  2021-07-27

2.  Seroprevalence of Asymptomatic Leishmania donovani among Laborers and Associated Risk Factors in Agricultural Camps of West Armachiho District, Northwest Ethiopia: A Cross-Sectional Study.

Authors:  Animen Ayehu; Yibeltal Aschale; Wossenseged Lemma; Animut Alebel; Ligabaw Worku; Ayalew Jejaw; Abebe Genetu Bayih
Journal:  J Parasitol Res       Date:  2018-11-28

3.  High-resolution melting analysis identifies reservoir hosts of zoonotic Leishmania parasites in Tunisia.

Authors:  Moufida Derghal; Abir Tebai; Ghofrane Balti; Hajer Souguir-Omrani; Jomaa Chemkhi; Adel Rhim; Ali Bouattour; Ikram Guizani; Youmna M'Ghirbi; Souheila Guerbouj
Journal:  Parasit Vectors       Date:  2022-01-08       Impact factor: 3.876

Review 4.  Domestic mammals as reservoirs for Leishmania donovani on the Indian subcontinent: Possibility and consequences on elimination.

Authors:  Anurag Kumar Kushwaha; Breanna M Scorza; Om Prakash Singh; Edgar Rowton; Phillip Lawyer; Shyam Sundar; Christine A Petersen
Journal:  Transbound Emerg Dis       Date:  2021-05-06       Impact factor: 4.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.